Metric Finance
LearnFAQ
LearnFAQ

Learn / STTK

NASDAQ: STTK

Shattuck Labs (STTK) stock, explained like you're 5

Shattuck Labs trades on the Nasdaq under the ticker STTK. It is a small cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 599 million dollars.

Ticker
STTK
Exchange
Nasdaq
Sector
Healthcare
Industry
Pharmaceutical Preparations
Size
Small cap, about 599 million dollars

Is Shattuck Labs a small, medium or large cap company?

No. Shattuck Labs is a small cap stock, not a large cap. Its market cap, which is the total value of all its shares, is about 599 million dollars.

Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.

How Shattuck Labs makes money

  • Selling medicines, medical devices or healthcare services.
  • Insurance premiums or hospital and clinic fees.
  • Research and licensing deals.

What moves STTK stock

  • Results from clinical trials and approvals from regulators.
  • Drug prices, insurance rules and government policy.
  • Patents running out and new competing treatments.

In the news lately

  • STTK Nov 2026 7.000 call (STTK261120C00007000) Stock Price, News, Quote & History (Yahoo! Finance Canada)
  • UBS upgrades Shattuck Labs stock to strong buy at USD 17 target (ad-hoc-news.de)
  • Why Shattuck Labs Stock Flew Nearly 5% Higher on Friday (The Motley Fool)
  • Here's Why We're Not At All Concerned With Shattuck Labs' (NASDAQ:STTK) Cash Burn Situation (Simply Wall Street)
  • Needham raises Shattuck Labs stock price target on HS trial plans (Investing.com)

Follow STTK in your daily brief

Each trading day at 5 PM ET we post what happened to Shattuck Labs and why it matters, in simple words. Free.

Start my free brief

Key terms to know before you follow STTK

  • Market cap
  • P/E ratio
  • EPS (earnings per share)
  • Earnings report
  • Volatility

Questions about Shattuck Labs stock

What does Shattuck Labs do?

Shattuck Labs trades on the Nasdaq under the ticker STTK. It is a small cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 599 million dollars.

What is the ticker symbol for Shattuck Labs?

Shattuck Labs trades under the ticker STTK on the Nasdaq.

What is Shattuck Labs's market cap?

Shattuck Labs is a small cap stock with a market cap of about 599 million dollars.

How does Shattuck Labs make money?

Selling medicines, medical devices or healthcare services. Insurance premiums or hospital and clinic fees. Research and licensing deals.

What moves STTK stock?

Results from clinical trials and approvals from regulators. Drug prices, insurance rules and government policy. Patents running out and new competing treatments.

How can I follow STTK stock every day?

Add STTK to your watchlist on Metric Finance. We post a free brief every trading day at 5 PM ET that explains what happened to the stocks you follow, in simple words.

Follow STTK daily

A free brief on Shattuck Labs and your other stocks, every trading day at 5 PM ET.

Start my free brief

Similar stocks

  • NVS · Novartis AG
  • AZN · Astrazeneca PLC
  • NVO · Novo Nordisk A S
  • VRTX · Vertex Pharmaceuticals Inc / Ma

Similar stocks

  • NVSNovartis AG
  • AZNAstrazeneca PLC
  • NVONovo Nordisk A S
  • VRTXVertex Pharmaceuticals Inc / Ma

Compare STTK: STTK vs NVS, STTK vs AZN, STTK vs NVO

Educational information, not financial advice. This guide explains the business in general terms and does not include live prices.

Metric Finance

Stocks explained like you're 5.

Product

  • Learn
  • FAQ
  • Your account

Legal

  • Privacy
  • Terms

Support

  • Contact
  • Unsubscribe

© 2026 Metric Finance

Built by Yashna & Vansh · Not investment advice · Market data may be delayed